High intensity interval training for lung cancer patients after surgery
Comparison of the Effects of Continuous Aerobic Exercise Training and Low Volume High Intensity Interval Training on Cardiopulmonary Exercise Capacity, Autonomic Function and Oxidative Stress in Operated Lung Cancer Patients
This study tests if a special exercise program can help lung cancer patients recover better after their surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Hacettepe University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Ankara, Sıhhiye) |
| Trial ID | NCT05837429 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of low volume high intensity interval training on patients who have undergone surgery for non-small cell lung cancer. Participants will be randomly assigned to two groups, each receiving different exercise protocols on a bicycle ergometer under physiotherapist supervision. The training consists of a warm-up, high-intensity intervals, and a cool-down phase, with the intensity tailored to each patient's maximal oxygen consumption. The study aims to assess the impact of this exercise regimen on patients' recovery and overall health post-surgery.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with non-small cell lung cancer, stage 3A or earlier, who have completed adjuvant treatments and are clinically stable in remission.
Not a fit: Patients who have undergone pneumonectomy surgery or have advanced COPD, cardiac disease, or orthopedic/neurological issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance recovery and improve the quality of life for lung cancer patients after surgery.
How similar studies have performed: Other studies have shown positive outcomes with high intensity interval training in cancer recovery, suggesting this approach may be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with Non-Small Cell Lung Cancer * Stage 3A and earlier * Operated and at least 6 months have expired since the surgery * Having completed adjuvant treatments such as chemotherapy and radiotherapy and at least 6 months have expired * Being clinically stable and in remission * Not having new recurrence and active cancer Exclusion Criteria: * Pneumonectomy surgery * Presence of symptoms, signs and diagnoses indicating the presence of lung and cardiac disease such as advanced COPD * Having any orthopedic or neurological problem that may prevent exercise * Presence of recurrence or active cancer
Where this trial is running
Ankara, Sıhhiye
- Ankara University — Ankara, Sıhhiye, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Hamide Sahin-Yildiz, Msc,PT — Ankara University
- Study coordinator: Hamide Sahin-Yildiz, Msc,PT
- Email: hamideshn128@gmail.com
- Phone: +903127364047
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.